The future of liraglutide, Byetta and Byetta LAR - Health Blog - WSJ

Links shared publicly online about this topic.

  • 2,142
    total visits

The future of liraglutide, Byetta and Byetta LAR - Health Blog - WSJ

feeds.wsjonline.com

Amylin makes the diabetes drug Byetta, and is working on a long-acting version.

View full resource at feeds.wsjonline.com

Tags: Diabetes, Diabetes Type 2 Medication, Diabetes Medication, Drug, FDA, Byetta, Victoza, Novo Nordisk

  • Share

Most Recently Shared on April 3, 2009 at 5:23 pm By:

WSJHealthBlog WSJ Health Blog

What FDA Diabetes Panel’s Novo Nordisk Vote Means for Amylin http://bit.ly/28TKK7

3 years ago...

Advertisement